Your browser doesn't support javascript.
loading
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.
Chatterjee, Gaurav; Sriram, Harshini; Ghogale, Sitaram; Deshpande, Nilesh; Khanka, Twinkle; Girase, Karishma; Verma, Shefali; Arolkar, Gauri; Dasgupta, Niharika; Narula, Gaurav; Shetty, Dhanalaxmi; Dhamne, Chetan; Moulik, Nirmalya R; Rajpal, Sweta; Patkar, Nikhil V; Banavali, Shripad; Gujral, Sumeet; Subramanian, Papagudi G; Tembhare, Prashant R.
Afiliação
  • Chatterjee G; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Sriram H; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Ghogale S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Deshpande N; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Khanka T; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Girase K; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Verma S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Arolkar G; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Dasgupta N; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Narula G; Department of Pediatric Oncology, Tata Memorial Hospital, Tata Memorial Centre, HBNI University, Mumbai, India.
  • Shetty D; Department of Cancer Cytogenetics, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Dhamne C; Department of Pediatric Oncology, Tata Memorial Hospital, Tata Memorial Centre, HBNI University, Mumbai, India.
  • Moulik NR; Department of Pediatric Oncology, Tata Memorial Hospital, Tata Memorial Centre, HBNI University, Mumbai, India.
  • Rajpal S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Patkar NV; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Banavali S; Department of Pediatric Oncology, Tata Memorial Hospital, Tata Memorial Centre, HBNI University, Mumbai, India.
  • Gujral S; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Subramanian PG; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
  • Tembhare PR; Haematopathology Laboratory, ACTREC, Tata Memorial Centre, HBNI University, Navi Mumbai, India.
Br J Haematol ; 196(2): 374-379, 2022 01.
Article em En | MEDLINE | ID: mdl-34476808
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunofenotipagem / Neoplasia Residual / Citometria de Fluxo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunofenotipagem / Neoplasia Residual / Citometria de Fluxo Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia